Charles River Laboratories International (CRL) operating margin
Charles River Laboratories International (CRL) had an operating margin of 10.0% in fiscal 2025 (the year ended December 31, 2025). That is 0.9 percentage points lower than the 10.9% of fiscal 2024. Figures as of 17 Nov 2026, 19:14 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Operating margin, fiscal 2025
- 10.0%
- Change on fiscal 2024
- −0.9 pts
- Highest on record
- 16.7%fiscal 2021
- Lowest on record
- -34.9%fiscal 2008
- Fiscal years on record
- 182008–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.
Charles River Laboratories International operating margin, in more detail
Across the 18 fiscal years on record (2008–2025), the highest was 16.7% in fiscal 2021 and the lowest -34.9% in fiscal 2008. The fiscal 2025 figure is higher than in 12% of the 17 earlier fiscal years on record, whose median is 14.6%.
Gross margin was 33.0% in fiscal 2025. Net margin was -3.6% in fiscal 2025.
Operating margin by fiscal year
- Operating margin
- Gross margin
- Net margin
Charles River Laboratories International operating margin, year by year
| Fiscal year | Operating margin | Change | Year ended | Gross margin | Net margin |
|---|---|---|---|---|---|
| 2025 | 10.0% | 0.9 pts down | 33.0% | -3.6% | |
| 2024 | 10.9% | 4.0 pts down | 32.9% | 0.3% | |
| 2023 | 14.9% | 1.4 pts down | 36.4% | 11.5% | |
| 2022 | 16.4% | 0.3 pts down | 36.8% | 12.2% | |
| 2021 | 16.7% | 1.9 pts up | — | 11.0% | |
| 2020 | 14.8% | 1.4 pts up | — | 12.5% | |
| 2019 | 13.4% | 1.2 pts down | — | 9.6% | |
| 2018 | 14.6% | 0.9 pts down | — | 10.0% | |
| 2017 | 15.5% | 1.4 pts up | — | 6.6% | |
| 2016 | 14.1% | 1.0 pts down | — | 9.2% | |
| 2015 | 15.1% | 1.5 pts up | — | 11.0% | |
| 2014 | 13.7% | 0.7 pts up | — | 9.8% | |
| 2013 | 13.0% | 1.7 pts down | — | 8.8% | |
| 2012 | 14.7% | 0.6 pts down | — | 8.7% | |
| 2011 | 15.3% | 41.6 pts up | — | 9.6% | |
| 2010 | -26.3% | 40.8 pts down | — | -29.7% | |
| 2009 | 14.5% | 49.4 pts up | — | 9.8% | |
| 2008 | -34.9% | — | — | -40.5% |
Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.
How to read it
It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.
Operating margin at health care companies of similar size
| Company | Operating margin | Fiscal year |
|---|---|---|
| Medpace Holdings MEDP | 21.1% | 2025 |
| Charles River Laboratories International CRL | 10.0% | 2025 |
| Ascendis Pharma ASND | -18.9% | 2025 |
The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.
Charles River Laboratories International, figure by figure
- Charles River Laboratories International market cap
- Charles River Laboratories International revenue
- Charles River Laboratories International earnings
- Charles River Laboratories International earnings per share (EPS)
- Charles River Laboratories International P/E ratio
- Charles River Laboratories International P/S ratio
- Charles River Laboratories International P/B ratio
- Charles River Laboratories International free cash flow
- Charles River Laboratories International dividend
- Charles River Laboratories International shares outstanding
- Charles River Laboratories International total debt
- Charles River Laboratories International cash on hand
- Charles River Laboratories International total assets
- Charles River Laboratories International return on equity (ROE)
- Charles River Laboratories International return on invested capital (ROIC)
Charles River Laboratories International (CRL) overview: price, valuation and scorecardAll health care companies by market value
Charles River Laboratories International operating margin: questions and answers
What is Charles River Laboratories International's operating margin?
Charles River Laboratories International (CRL) had an operating margin of 10.0% in fiscal 2025 (the year ended December 31, 2025). That is 0.9 percentage points lower than the 10.9% of fiscal 2024.
Is Charles River Laboratories International's operating margin high or low compared with its own history?
The fiscal 2025 figure is higher than in 12% of the 17 earlier fiscal years on record, whose median is 14.6%.
What are the highest and lowest operating margin figures on record for Charles River Laboratories International?
Across the 18 fiscal years on record (2008–2025), the highest was 16.7% in fiscal 2021 and the lowest -34.9% in fiscal 2008.
What are Charles River Laboratories International's gross and net margins?
Gross margin was 33.0% in fiscal 2025. Net margin was -3.6% in fiscal 2025.
How is Charles River Laboratories International's operating margin calculated?
Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.
Fiscal years are named for the calendar year they end in.
Learn: operating margin
All stocks guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Charles River Laboratories International (CRL) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/CRL/operating-margin
Underlying data: the company's filings with the SEC and Yahoo Finance.